相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Human antibodies targeting ENPP1 as candidate therapeutics for cancers
Xiaojie Chu et al.
FRONTIERS IN IMMUNOLOGY (2023)
Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study
Funda Meric-Bernstam et al.
CLINICAL CANCER RESEARCH (2023)
Design, synthesis and biological evaluation studies of novel small molecule ENPP1 inhibitors for cancer immunotherapy
Mukesh Gangar et al.
BIOORGANIC CHEMISTRY (2022)
Musculoskeletal Comorbidities and Quality of Life in ENPP1-Deficient Adults and the Response of Enthesopathy to Enzyme Replacement Therapy in Murine Models
Carlos R. Ferreira et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2022)
CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory
Yujiro Kidani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer
Borja Ruiz-Fernandez de Cordoba et al.
CANCER DISCOVERY (2022)
Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE
Jesus San-Miguel et al.
BLOOD (2022)
Biochemistry, Cell Biology, and Pathophysiology of the Innate Immune cGAS-cGAMP-STING Pathway
Christopher Ritchie et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2022)
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer
Roy S. Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
First-in-human experience using RBS2418, an oral ENPP1 inhibitor within an expanded access protocol in combination with pembrolizumab in a patient with metastatic adrenal cancer.
Ildiko Csiki et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors
Emerson A. Lim et al.
CLINICAL CANCER RESEARCH (2022)
IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy
Alvaro Teijeira et al.
CLINICAL CANCER RESEARCH (2021)
Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis
Jun Li et al.
CANCER DISCOVERY (2021)
High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target
Hanzhi Wang et al.
PLOS ONE (2021)
TRIAL OF SNX281, A SYSTEMICALLY DELIVERED SMALL MOLECULE STING AGONIST, IN SOLID TUMORS AND LYMPHOMAS
Judy Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Heterogenous presence of neutrophil extracellular traps in human solid tumours is partially dependent on IL-8
Carlos E. de Andrea et al.
JOURNAL OF PATHOLOGY (2021)
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer An Analysis of Data From the I-SPY2 Randomized Clinical Trial
W. Fraser Symmans et al.
JAMA ONCOLOGY (2021)
Orally available ENPP1 inhibitor, TXN10128, restores STING activation in tumor microenvironment and confers anti-tumor responses in combination with immune checkpoint blockade
Sungjoon Kim et al.
MOLECULAR CANCER THERAPEUTICS (2021)
The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer
John Kwon et al.
CANCER DISCOVERY (2020)
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
Kurt A. Schalper et al.
NATURE MEDICINE (2020)
CD39 Identifies the CD4+ Tumor-Specific T-cell Population in Human Cancer
Kim E. Kortekaas et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Phase II study of intratumoral MK-1454 plus pembrolizumab compared with pembrolizumab monotherapy as first-line treatment for metastatic or unresectable, recurrent head and neck squamous cell carcinoma
K. J. Harrington et al.
ANNALS OF ONCOLOGY (2020)
Structure-Aided Development of Small-Molecule Inhibitors of ENPP1, the Extracellular Phosphodiesterase of the Immunotransmitter cGAMP
Jacqueline A. Carozza et al.
CELL CHEMICAL BIOLOGY (2020)
LRRC8A:C/E Heteromeric Channels Are Ubiquitous Transporters of cGAMP
Lauren J. Lahey et al.
MOLECULAR CELL (2020)
Extracellular cGAMP is a cancer-cell-produced immunotransmitter involved in radiation-induced anticancer immunity
Jacqueline A. Carozza et al.
NATURE CANCER (2020)
Canonical and non-canonical adenosinergic pathways
E. Ferretti et al.
IMMUNOLOGY LETTERS (2019)
ENPP1 in the Regulation of Mineralization and Beyond
Fiona Roberts et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
SLC19A1 Is an Importer of the Immunotransmitter cGAMP
Christopher Ritchie et al.
MOLECULAR CELL (2019)
The role of NK cells and CD39 in the immunological control of tumor metastases
Haiyan Zhang et al.
ONCOIMMUNOLOGY (2019)
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Selena Vigano et al.
FRONTIERS IN IMMUNOLOGY (2019)
Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
Simone de Leve et al.
FRONTIERS IN IMMUNOLOGY (2019)
ENPP1, an Old Enzyme with New Functions, and Small Molecule Inhibitors-A STING in the Tale of ENPP1
Kenneth I. Onyedibe et al.
MOLECULES (2019)
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
Xian-Yang Li et al.
CANCER DISCOVERY (2019)
Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity
Linda Schadt et al.
CELL REPORTS (2019)
In Vivo Labeling by CD73 Marks Multipotent Stromal Cells and Highlights Endothelial Heterogeneity in the Bone Marrow Niche
Martin Breitbach et al.
CELL STEM CELL (2018)
Chromosomal instability drives metastasis through a cytosolic DNA response
Samuel F. Bakhoum et al.
NATURE (2018)
Emerging Roles of Nucleoside Transporters
Marcal Pastor-Anglada et al.
FRONTIERS IN PHARMACOLOGY (2018)
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
Assaf Marcus et al.
IMMUNITY (2018)
Design of amidobenzimidazole STING receptor agonists with systemic activity
Joshi M. Ramanjulu et al.
NATURE (2018)
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment
Arabella Young et al.
CANCER RESEARCH (2018)
Radiation effects on antitumor immune responses: current perspectives and challenges
Thomas Walle et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
Bertrand Allard et al.
IMMUNOLOGICAL REVIEWS (2017)
cGAS surveillance of micronuclei links genome instability to innate immunity
Karen J. Mackenzie et al.
NATURE (2017)
Mitotic progression following DNA damage enables pattern recognition within micronuclei
Shane M. Harding et al.
NATURE (2017)
Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors
Sang-Yong Lee et al.
MEDCHEMCOMM (2017)
Signalling strength determines proapoptotic functions of STING
Muhammet F. Gulen et al.
NATURE COMMUNICATIONS (2017)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille-Box et al.
NATURE COMMUNICATIONS (2017)
Targeting immunosuppressive adenosine in cancer (vol 17, pg 709, 2017)
Dipti Vijayan et al.
NATURE REVIEWS CANCER (2017)
Time to grow: circadian regulation of growth and metabolism in photosynthetic organisms
Santiago Mora-Garcia et al.
CURRENT OPINION IN PLANT BIOLOGY (2017)
CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells
Eriko Katsuta et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
Arabella Young et al.
CANCER CELL (2016)
Extracellular Adenosine Production by ecto-5′-Nucleotidase (CD73) Enhances Radiation-Induced Lung Fibrosis
Florian Wirsdoerfer et al.
CANCER RESEARCH (2016)
STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation
Henrique Lemos et al.
CANCER RESEARCH (2016)
ENPP1 processes protein ADP-ribosylation in vitro
Luca Palazzo et al.
FEBS JOURNAL (2016)
Plasma cell alloantigen ENPP1 is expressed by a subset of human B cells with potential regulatory functions
Jeongheon Yoon et al.
IMMUNOLOGY AND CELL BIOLOGY (2016)
Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer
Qing Chen et al.
NATURE (2016)
Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps
Juwon Park et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
CD73 Pathway Contributes to the Immunosuppressive Ability of Mesenchymal Stem Cells in Intraocular Autoimmune Responses
Xiteng Chen et al.
STEM CELLS AND DEVELOPMENT (2016)
Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape
Itsaso Montalban del Barrio et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Transmission of innate immune signaling by packaging of cGAMP in viral particles
Matteo Gentili et al.
SCIENCE (2015)
Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1
Ryou-u Takahashi et al.
NATURE COMMUNICATIONS (2015)
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses
Paul A. Beavis et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Extracellular nucleotide and nucleoside signaling in vascular and blood disease
Marco Idzko et al.
BLOOD (2014)
Cytosolic DNA sensing via the stimulator of interferon genes adaptor: Yin and Yang of immune responses to DNA
Henrique Lemos et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
A Novel Mechanism of B Cell-Mediated Immune Suppression through CD73 Expression and Adenosine Production
Hiroaki Kaku et al.
JOURNAL OF IMMUNOLOGY (2014)
Vascular calcification is dependent on plasma levels of pyrophosphate
Koba A. Lomashvili et al.
KIDNEY INTERNATIONAL (2014)
Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
Jonathan Cools-Lartigue et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Cutting Edge: DNA Sensing via the STING Adaptor in Myeloid Dendritic Cells Induces Potent Tolerogenic Responses
Lei Huang et al.
JOURNAL OF IMMUNOLOGY (2013)
Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP
Andrea Ablasser et al.
NATURE (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Enpp1: A Potential Facilitator of Breast Cancer Bone Metastasis
Wen Min Lau et al.
PLOS ONE (2013)
Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA
Jiaxi Wu et al.
SCIENCE (2013)
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Lijun Sun et al.
SCIENCE (2013)
A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
Alberto L. Horenstein et al.
ONCOIMMUNOLOGY (2013)
Immunity, inflammation and cancer: a leading role for adenosine
Luca Antonioli et al.
NATURE REVIEWS CANCER (2013)
Expression, purification, crystallization and preliminary X-ray crystallographic analysis of Enpp1
Kazuki Kato et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2012)
CD73-Deficient Mice Are Resistant to Carcinogenesis
John Stagg et al.
CANCER RESEARCH (2012)
Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation
Anurag Gupta et al.
JOURNAL OF IMMUNOLOGY (2012)
Cellular function and molecular structure of ecto-nucleotidases
Herbert Zimmermann et al.
PURINERGIC SIGNALLING (2012)
The convergence of radiation and immunogenic cell death signaling pathways
Encouse B. Golden et al.
FRONTIERS IN ONCOLOGY (2012)
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
John Stagg et al.
CANCER RESEARCH (2011)
The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
Byron C. Burnette et al.
CANCER RESEARCH (2011)
Characterization of Monoclonal Antibodies to the Plasma Cell Alloantigen ENPP1
Sadia Abbasi et al.
HYBRIDOMA (2011)
Expression of NPP1 is regulated during atheromatous plaque calcification
Yvonne Nitschke et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
Sergey Ryzhov et al.
JOURNAL OF IMMUNOLOGY (2011)
Haptoglobin: Basic and Clinical Aspects
Andrew P. Levy et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
A2A Adenosine Receptor May Allow Expansion of T Cells Lacking Effector Functions in Extracellular Adenosine-Rich Microenvironments
Akio Ohta et al.
JOURNAL OF IMMUNOLOGY (2009)
P2 receptors, platelet function and pharmacological implications
Christian Gachet
THROMBOSIS AND HAEMOSTASIS (2008)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles
Marcello Baroni et al.
FASEB JOURNAL (2007)
Pathophysiology and therapeutic potential of purinergic signaling
G Burnstock
PHARMACOLOGICAL REVIEWS (2006)
Cutting edge:: Conventional CD8α+ dendritic cells are generally involved in priming CTL immunity to viruses
GT Belz et al.
JOURNAL OF IMMUNOLOGY (2004)
Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion
B Grobben et al.
CELL AND TISSUE RESEARCH (2002)
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase
DH Munn et al.
SCIENCE (2002)
Adenosine acts through an A3 receptor to prevent the induction of murine anti-CD3-activated killer T cells
DW Hoskin et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
分享论文
